Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas

Journal of Cranio-Maxillofacial Surgery

Volumn 36, Issue 5, 2008, Pages 285-292

  Schiefke, Franziska ^a   Hildebrandt, Guido ^a   Pohlmann, Stefan ^a   Heinicke, Frank ^a   Hemprich, Alexander ^a   Frerich, Bernhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

HDR brachytherapy; head and neck oncology; recurrence; salvage therapy; squamous cell carcinoma; tumour surgery

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; INTRAOPERATIVE PERIOD; MALE; MYOCUTANEOUS FLAP; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RECURRENT CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MICROSURGERY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; REOPERATION; SALVAGE THERAPY; SURGICAL FLAPS;

EID: 44449168464     PISSN: 10105182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcms.2007.08.009     Document Type: Article

References (19)

1. Binahmed A., Nason R.W., and Abdoh A.A. The clinical significance of the positive surgical margin in oral cancer. Oral Oncol (2006 Dec 13) 10.1016/j.oraloncology.2006.10.001 [Epub ahead of print]
2. Chandu A., Adams G., and Smith A.C. Factors affecting survival in patients with oral cancer: an Australian perspective. Int J Oral Maxillofac Surg 34 (2005) 514-520
3. Chen K.Y., Mohr R.M., and Silverman C.L. Interstitial iodine 125 in advanced recurrent squamous cell carcinoma of the head and neck with follow-up evaluation of carotid artery by ultrasound. Ann Otol Rhinol Laryngol 105 (1996) 955-961
4. Chmura S.J., Milano M.T., and Haraf D.J. Reirradiation of recurrent head and neck cancers with curative intent. Semin Oncol 31 (2004) 816-821
5. Garzino-Demo P., Dell'Acqua A., Dalmasso P., Fasolis M., La Terra Maggiore G.M., Ramieri G., Berrone S., Rampino M., and Schena M. Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma. J Craniomaxillofac Surg 34 (2006) 344-350
6. Hepel J.T., Syed A.M., Puthawala A., Sharma A., and Frankel P. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1444-1450
7. Howaldt H.P., Vorast H., Blecher J.C., Reicherts M., and Kainz M. Ergebnisse aus dem DÖSAK-Tumorregister. Mund Kiefer Gesichtschir 1 Suppl. 4 (2000) S216-S225
8. Kolotas C., Tselis N., Sommerlad M., Roddiger S., Schnabel T., Baltas D., Kalogera-Fountzila A., Fountzilas G., and Zamboglou N. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial (192)Ir HDR brachytherapy. Strahlenther Onkol 183 (2007) 69-75
9. Lang S., Wollenberg B., Dellian M., Steuer-Vogt M.K., Schwenzer K., Sautier W., Chucholowski M., Eckel R., Faas I., Wilmes E., Ehrenfeld M., Arnold W., Kastenbauer E., and Holzel D. Klinische und epidemiologische Daten zu Malignomen des Kopf-Hals-Bereichs. Laryngorhinootologie 81 (2002) 499-508
10. Moscoso J.F., Urken M.L., Dalton J., Wesson M.F., and Biller H.F. Simultaneous interstitial radiotherapy with regional or free-flap reconstruction, following salvage surgery of recurrent head and neck carcinoma. Analysis of complications. Arch Otolaryngol Head Neck Surg 120 (1994) 965-972
11. Park R.I., Liberman F.Z., Lee D.J., Goldsmith M.M., and Price J.C. Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head and neck. Laryngoscope 101 (1991) 405-410
12. Pellizzon A.C., dos Santos Novaes P.E., Conte Maia M.A., Ferrigno R., Fogarolli R., Salvajoli J.V., and Kowalski L.P. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer. Head Neck 27 (2005) 1035-1041
13. Pericot J., Escriba J.M., Valdes A., Biosca M.J., Monner A., Castellsague X., Galiana R., Piulachs P., Escutia E., and Mari A. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx. J Craniomaxillofac Surg 28 (2000) 49-55
14. Quon H., and Harrison L.B. Brachytherapy in the treatment of head and neck cancer. Oncology (Huntingt) 16 (2002) 1379-1393
15. Ross D.A., Hundal J.S., Son Y.H., Ariyan S., Shin J., Lowlicht R., and Sasaki C.T. Microsurgical free flap reconstruction outcomes in head and neck cancer patients after surgical extirpation and intraoperative brachytherapy. Laryngoscope 114 (2004) 1170-1176
16. Shasha D., Harrison L.B., and Chiu-Tsao S.T. The role of brachytherapy in head and neck cancer. Semin Radiat Oncol 8 (1998) 270-281
17. Stafford N., and Dearnaley D. Treatment of 'inoperable' neck nodes using surgical clearance and postoperative interstitial irradiation. Br J Surg 75 (1988) 62-64
18. Strnad V., Melzner W., Geiger M., Zenk J., Waldfahrer F., Lotter M., Ott O., Seeger A., Iro H., and Sauer R. Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients. Strahlenther Onkol 181 (2005) 762-767
19. Sutton D.N., Brown J.S., Rogers S.N., Vaughan E.D., and Woolgar J.A. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32 (2003) 30-34